Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials
Top Cited Papers
- 13 July 2006
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 152 (1) , 27-38
- https://doi.org/10.1016/j.ahj.2005.09.015
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidityEuropean Heart Journal, 2005
- Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetesDiabetic Medicine, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)The Lancet, 1998
- Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trialThe American Journal of Cardiology, 1995
- Glycation Products and the Pathogenesis of Diabetic ComplicationsDiabetes Care, 1992
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- PREVENTION OF DETERIORATION OF RENAL AND SENSORY-NERVE FUNCTION BY MORE INTENSIVE MANAGEMENT OF INSULIN-DEPENDENT DIABETIC PATIENTSThe Lancet, 1983
- Prognosis of diabetics with diabetes onset before the age of thirtyoneDiabetologia, 1978